CH515227A - Verfahren zur Herstellung von 21-Fluor- 4,6-pregnadienen - Google Patents
Verfahren zur Herstellung von 21-Fluor- 4,6-pregnadienenInfo
- Publication number
- CH515227A CH515227A CH1100967A CH1100967A CH515227A CH 515227 A CH515227 A CH 515227A CH 1100967 A CH1100967 A CH 1100967A CH 1100967 A CH1100967 A CH 1100967A CH 515227 A CH515227 A CH 515227A
- Authority
- CH
- Switzerland
- Prior art keywords
- methylene
- fluoro
- dione
- chloro
- pregnadiene
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH903971A CH524590A (de) | 1966-08-11 | 1967-08-04 | Verfahren zur Herstellung von 21-Fluor- 4,6-pregnadienen |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DESC039385 | 1966-08-11 | ||
| DESC040710 | 1967-05-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH515227A true CH515227A (de) | 1971-11-15 |
Family
ID=25993399
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH1100967A CH515227A (de) | 1966-08-11 | 1967-08-04 | Verfahren zur Herstellung von 21-Fluor- 4,6-pregnadienen |
Country Status (12)
| Country | Link |
|---|---|
| BE (1) | BE702583A (da) |
| CH (1) | CH515227A (da) |
| DE (2) | DE1593515C3 (da) |
| DK (1) | DK117227B (da) |
| ES (1) | ES343859A1 (da) |
| FI (1) | FI45172C (da) |
| FR (1) | FR1561096A (da) |
| GB (1) | GB1196476A (da) |
| IL (1) | IL28465A (da) |
| NL (1) | NL152267B (da) |
| NO (1) | NO126525B (da) |
| SE (1) | SE320067B (da) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19908762A1 (de) * | 1999-02-18 | 2000-08-31 | Jenapharm Gmbh | Verwendung von Dienogest in hoher Dosierung |
-
1966
- 1966-08-11 DE DE19661593515 patent/DE1593515C3/de not_active Expired
-
1967
- 1967-05-13 DE DE19671643021 patent/DE1643021A1/de active Pending
- 1967-06-28 SE SE9525/67*A patent/SE320067B/xx unknown
- 1967-07-11 FI FI191467A patent/FI45172C/fi active
- 1967-08-01 GB GB3531267A patent/GB1196476A/en not_active Expired
- 1967-08-02 DK DK394967A patent/DK117227B/da unknown
- 1967-08-04 CH CH1100967A patent/CH515227A/de not_active IP Right Cessation
- 1967-08-05 ES ES343859A patent/ES343859A1/es not_active Expired
- 1967-08-07 IL IL2846567A patent/IL28465A/en unknown
- 1967-08-10 NL NL6711020A patent/NL152267B/xx unknown
- 1967-08-10 NO NO16932167A patent/NO126525B/no unknown
- 1967-08-10 FR FR1561096D patent/FR1561096A/fr not_active Expired
- 1967-08-11 BE BE702583D patent/BE702583A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK117227B (da) | 1970-03-31 |
| ES343859A1 (es) | 1968-10-01 |
| NL6711020A (da) | 1968-02-12 |
| DE1593515A1 (de) | 1970-08-13 |
| NO126525B (da) | 1973-02-19 |
| IL28465A (en) | 1972-01-27 |
| FR1561096A (da) | 1969-03-28 |
| FI45172C (fi) | 1972-04-10 |
| GB1196476A (en) | 1970-06-24 |
| BE702583A (da) | 1968-02-12 |
| FI45172B (da) | 1971-12-31 |
| DE1593515C3 (de) | 1975-08-14 |
| DE1593515B2 (de) | 1975-01-09 |
| NL152267B (nl) | 1977-02-15 |
| DE1643021A1 (de) | 1971-03-11 |
| SE320067B (da) | 1970-02-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CH635594A5 (de) | Verfahren zur herstellung von neuen gona-4,9(10)-dienen. | |
| CH515227A (de) | Verfahren zur Herstellung von 21-Fluor- 4,6-pregnadienen | |
| CH496683A (de) | Verfahren zur Herstellung neuer D-Homosteroide | |
| AT274260B (de) | Verfahren zur Herstellung von neuen 21-Fluor-Δ<4,6>-pregnadienen | |
| DE1468632C (de) | öalpha Acetylthio 4 en 3 on steroide und Verfahren zu deren Herstellung | |
| CH524590A (de) | Verfahren zur Herstellung von 21-Fluor- 4,6-pregnadienen | |
| AT224277B (de) | Verfahren zur Herstellung von neuen 16-Methylen-17α-acetoxy-progesteron-derivaten | |
| DE1618977C (de) | Nitroostratnene und Verfahren zu deren Herstellung | |
| DE1668685C3 (de) | 17-Hydroxy- und 17-Acyloxy-6 beta, 7 beta-epoxy-1 alpha, 2 alpha-methylen-4-pregnen-3,20-dione, Verfahren zu deren Herstellung sowie diese enthaltende Mittel | |
| DE1493164C3 (de) | lbeta-Halomethylandrostane und Verfahren zu ihrer Herstellung | |
| DE1813083B2 (de) | 11 beta-Methyl-19-norpregn-4-en 3,20-dione, Verfahren zu ihrer Herstellung sowie diese enthaltendes Mittel | |
| CH553759A (de) | Verfahren zur herstellung von neuen 4-chlor-1,2(alpha)-methylen-(delta)4,6-pregnadien-17(alpha)-ol-3,20-dion oder dessen 17estern. | |
| DE1922126C3 (de) | 6,17-Dichlor-A4'6 -pregnadiene, Verfahren zu deren Herstellung, diese enthaltende Arzneimittel sowie | |
| AT233177B (de) | Verfahren zur Herstellung des neuen 6α-Methyl-17 α-hydroxyprogesterons und seiner Ester | |
| AT240540B (de) | Verfahren zur Herstellung von 4-Chlor-Δ<4>-3-ketosteroidverbindungen | |
| AT235477B (de) | Verfahren zur Herstellung von neuen, mit einem Isoxazolring kondensierten Steroidverbindungen | |
| CH493506A (de) | Verfahren zur Herstellung von neuen Nitroöstratrienen | |
| DE1299635B (de) | In 3-Stellung unsubstituierte ª€ -19-nor-Androstene und ein Verfahren zu deren Herstellung | |
| DE1156805B (de) | Verfahren zur Herstellung von A-nor-Verbindungen der Pregnanreihe | |
| CH493507A (de) | Verfahren zur Herstellung von 1B-Methyl-2,3a-methylen-steroiden | |
| DE1468632B1 (de) | 6alpha-Acetylthio-4-en-3-on-steroide und Verfahren zu deren Herstellung | |
| DE1195746B (de) | Verfahren zur Herstellung von gegebenenfalls S-alkylierten oder S-acylierten 7alpha-Mercapto-delta 1,4-3-keto-steroiden | |
| DE1768673B1 (de) | 6alpha,9alpha-Difluorprednisolon-17,21-diester | |
| DE1119267B (de) | Verfahren zur Herstellung von gonadenhemmenden Derivaten des 17-epi-Oestriols | |
| DE1193041B (de) | Verfahren zur Herstellung von delta 7-, delta 7,9,(11)-, delta 7,9,(11),16-, delta 7, delta 8- oder delta 8,16-Steroiden |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased |